Erratum to: Malignant Peritoneal Mesothelioma Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Is GLUT1 Expression a Major Prognostic Factor? A Preliminary Study
Authors:
J. Hommell-Fontaine, MD, S. Isaac, MD, G. Passot, MD, E. Decullier, PhD, A. Traverse-Glehen, MD, PhD, E. Cotte, MD, PhD, B. You, MD, PhD, F. Mohamed, MD, F. N. Gilly, MD, PhD, O. Glehen, MD, PhD, F. Berger, MD, PhD
Erratum to: Malignant Peritoneal Mesothelioma Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Is GLUT1 Expression a Major Prognostic Factor? A Preliminary Study
Authors
J. Hommell-Fontaine, MD S. Isaac, MD G. Passot, MD E. Decullier, PhD A. Traverse-Glehen, MD, PhD E. Cotte, MD, PhD B. You, MD, PhD F. Mohamed, MD F. N. Gilly, MD, PhD O. Glehen, MD, PhD F. Berger, MD, PhD